Navigation Links
Myriant Technologies, Inc. Announces J. Brian Ferguson to Join Advisory Board
Date:3/2/2011

QUINCY, Mass., March 2, 2011 /PRNewswire/ -- Myriant Technologies, Inc. (Myriant), a privately-held, biotech developer and manufacturer of renewable bio-based chemicals, announces the addition of J. Brian Ferguson to its Board of Advisors effective immediately.  Mr. Ferguson, 56, is the former CEO and Chairman of Eastman Chemical Company, a global chemical company engaged in the manufacture and sale of a broad portfolio of chemicals, plastics and fibers.  

(Logo: http://photos.prnewswire.com/prnh/20091021/NE96331LOGO)

"I am honored and excited to have Brian Ferguson join our Board of Advisors.  Between his tenure as CEO of Eastman and chairmanship of the American Chemistry Council, it is hard to imagine someone with a stronger grasp of the issues and influences surrounding our business," said Stephen J. Gatto, Chairman and Chief Executive Officer of Myriant.  "We look forward to Mr. Ferguson bringing his wealth of experience and global understanding of the business to Myriant as we transform the chemical markets with our bio-based platform."

"Myriant is an exciting young company that is shaping the new chemical industry landscape by creating the products and processes of the future," said Mr. Ferguson.  "I'm very happy to have a part in this visionary leadership and Myriant's continuing achievements in bio-based chemicals."

Mr. Ferguson served as CEO and Chairman of Eastman from January of 2002 through June of 2008, and as Executive Chairman of the Board from June 2008 through December 2010.  Prior to his roles as CEO/Chairman, Mr. Ferguson was President of Eastman's Chemicals Group where he had direct responsibility for all chemicals-based business organizations, as well as the manufacturing, sales, pricing and product management, technology and geographical aspects of the business group.

Mr. Ferguson has served as a director of Nextera Energy, Inc. (formerly FPL Group) since 2005.  He was Chairman of the American Chemistry Council in 2010, and was a member of the Business Roundtable and the board of the National Association of Manufacturers prior to his retirement from Eastman.  

Mr. Ferguson joins existing Advisory Board members Norman R. Augustine, Robert McFarlane and Chairman R. James Woolsey. Myriant's Advisory Board advises the company's Board of Directors and management in the Company's strategic decision making process and other matters including business and organizational development, technology, policy and outreach.

With a world-renowned team of molecular biologists, engineers and chemists, Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable commercialization of high-value specialty chemicals.  The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant is headquartered in Quincy, Massachusetts. Details are available at www.myriant.com.Contacts:Myriant - Samuel G. McConnell, Sr.VP, Corporate DevelopmentTelephone:  (617) 657-5207  Email: smcconnell@myriant.com
'/>"/>

SOURCE Myriant Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Myriant Technologies, Inc. Announces US$60 Million Strategic Equity Investment From PTT Chemical Group
2. Gov. Jindal Announces Myriant Technologies to Begin Construction of New, Sustainable Specialty Chemical Plant in Lake Providence
3. Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project
4. Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants
5. Myriant Technologies LLC Announces Appointment of Science Advisory Board Members
6. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
7. Palatin Technologies, Inc. Announces Pricing of Public Offering of Common Stock and Warrants
8. Palatin Technologies, Inc. Announces Proposed Public Offering of Common Stock and Warrants
9. Palatin Technologies, Inc. December 31, 2010 Quarter Results; Teleconference and Webcast to be Held on February 24, 2011
10. AMDeCs Vendor Program Expands Focus with Addition of BioStorage Technologies, Offering Preferred Pricing on Tissue Storage and Cold Chain Logistics Services
11. Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... , Jan. 23, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: ... into an underwriting agreement with Rodman & Renshaw, a ... as sole book running manager and representative of several underwriters, ... a firm commitment basis a minimum of 2,105,264 shares ... to purchase a minimum of 1,052,632 shares of common ...
(Date:1/23/2017)... 2017 /PRNewswire/ - Resverlogix Corp. ("Resverlogix" or the "Company") ... New Zealand based Phase 1 trial ... remarkable results in reducing inflamed protein biomarkers in patients ... is believed that this is the first time in ... can be made between epigenetic regulation and its potential ...
(Date:1/23/2017)... ... 2017 , ... AxioMed will be presenting its viscoelastic cervical ... Montego Bay, Jamaica from January 26-28th. “We’re excited to be presenting the benefits ... the simplicity of the surgical technique,” said Jake Lubinski, President of AxioMed. ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... to bring to market a pioneering medical device for the treatment of Age-Related ... engagement contract with Emergo, a global regulatory consultancy that helps companies like ours ...
Breaking Biology Technology:
(Date:1/12/2017)... Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... technologies, today announced that it has signed agreements with ... and the Middle East for ... marks the first wave of international distribution agreements for ... blood samples. The initial partners will introduce ...
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
(Date:1/3/2017)... 3, 2017 Onitor, provider of digital health ... Track, an innovative biometric data-driven program designed to aid ... at the 2017 Consumer Electronics Show (CES) in ... the U.S., the World Health Organization (WHO), have identified ... adults who are overweight or obese. WHO also states ...
Breaking Biology News(10 mins):